Online inquiry

IVTScrip™ mRNA-Human ARRB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25075MR)

This product GTTS-WK25075MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRB1 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_004041.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 408
UniProt ID P49407
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRB1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25075MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27451MR IVTScrip™ mRNA-Human ARL8B, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARL8B
GTTS-WK16799MR IVTScrip™ mRNA-Human APBB1IP, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APBB1IP
GTTS-WK26770MR IVTScrip™ mRNA-Human ARFGAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARFGAP2
GTTS-WK18817MR IVTScrip™ mRNA-Human ANKRD31, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD31
GTTS-WK25579MR IVTScrip™ mRNA-Human ARGLU1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARGLU1
GTTS-WK17924MR IVTScrip™ mRNA-Human ANKRD39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD39
GTTS-WK14061MR IVTScrip™ mRNA-Human ADORA2B, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADORA2B
GTTS-WK7768MR IVTScrip™ mRNA-Human ADRB2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADRB2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →